The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry
Danone has acquired Belgian biotics firm The Akkermansia Company (TAC), strengthening its position in gut health and expanding its science-driven portfolio in line with its Renew strategy.
Founded in 2004, TAC is known for its work on Akkermansia muciniphila MucT, a clinically studied strain shown to support gut barrier function, reduce inflammation and help manage metabolic conditions such as obesity, diabetes and cardiovascular disease.
The acquisition supports Danone’s focus on science and innovation as it looks to meet growing consumer demand for health-oriented products.
The deal marks a deeper move into biotics and microbiome-based solutions as part of Danone’s broader commitment to health through food.
Terms of the transaction were not disclosed.
Top image: © The Akkermansia Company
Related posts
Vadasz introduces its first seasonal innovation, Sprout Kimchi
Tereos unveils corn-based ingredient to enhance fibre intake
Busting the biggest myths about gut health
Squeaky Bean expands portfolio with ‘first-to-market’ fermented vegetable pies
Balchem launches StabiliPro excipient portfolio for improved probiotic stability
Bio&Me launches new protein and fibre bars targeting female consumers
.jpg)